NCT01112722 - Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis | Biotech Hunter

Enrollment

363

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

December 31, 2016

Conditions

Osteoarthritis of the Knee

Interventions

BIOLOGICAL

Apitox, purified honeybee toxin, lyophilized in saline

intradermal injections of 0.1mg apitox in 0.1ml WFI over 12 weeks treatment period, injections twice weekly range from 1 to 20 injections

BIOLOGICAL

histamine

imitates pain and erythema of honeybee venom

Trial Locations (15)

33155

AppleMed Research Inc., Miami

33316

Schrock Orthopedics Research, Fort Lauderdale

33781

Radiant Research Inc., Pinellas Park

36542

Functional Research LLC, Gulf Shores

37912

PMG Research of Knoxville, Knoxville

37938

PMG Research of Knoxville, Knoxville

43212

Radiant Research Inc Columbus, Columbus

73119

Hillcrest Clinical Research, Olahoma City

78745

Tekton Research, Austin

87512

Tucson Orthopaedic Institute, Tucson

90036

Axis Clinical Trials, Los Angeles

91360

Westlake Medical Research, Thousand Oaks

91786

SC Clinical Research Inc., Upland

92844

SC Clinical Research Inc., Garden Grove

02301

Beacon Clinical, Brockton